Currently also: Chief Informatics and Technology Officer (CITO) at Pangea Botanica, London/UK and Berlin/Germany

Previous positions:

Director Digital Chemistry at NUVISAN Berlin

Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge

Co-founder of Healx Ltd.

Co-founder of PharmEnable Ltd.

Personal Website

  • Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
  • Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
  • Collaborating with academic research groups, as well as  pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
  • Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
  • Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
  • Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
  • Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics

Publications

Molecular Similarity Searching Using COSMO Screening Charges (COSMO/3PP)
A Bender, A Klamt, K Wichmann, M Thormann, RC Glen
Lecture Notes in Computer Science
(2005)
3695 LNBI
Screening for Dihydrofolate Reductase Inhibitors Using MOLPRINT 2D, a Fast Fragment-Based Method Employing the Naïve Bayesian Classifier: Limitations of the Descriptor and the Importance of Balanced Chemistry in Training and Test Sets
A Bender, HY Mussa, RC Glen
J Biomol Screen
(2005)
10
Discussion of measures of enrichment in virtual screening: Comparing the information content of descriptors with increasing levels of sophistication
A Bender, RC Glen
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2005)
45
A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication
A Bender, RC Glen
Journal of Chemical Information and Modeling
(2005)
45
Assessment of structural diversity in combinatorial synthesis.
S Fergus, A Bender, DR Spring
Current opinion in chemical biology
(2005)
9
General melting point prediction based on a diverse compound data set and artificial neural networks.
M Karthikeyan, RC Glen, A Bender
Journal of chemical information and modeling
(2005)
45
Encoding and Decoding Graphical Chemical Structures as Two-Dimensional (PDF417) Barcodes
M Karthikeyan, A Bender
Journal of chemical information and modeling
(2005)
45
Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT 3D).
A Bender, HY Mussa, GS Gill, RC Glen
Journal of medicinal chemistry
(2004)
47
Molecular similarity: A key technique in molecular informatics
A Bender, RC Glen
Organic and Biomolecular Chemistry
(2004)
2
Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance
A Bender, HY Mussa, RC Glen, S Reiling
J Chem Inf Comput Sci
(2004)
44

Research Interest Groups

Telephone number

01223 762983

Email address